Membrane preparations obtained from a stabilized L-form of Streptococcus pyogenes are incapable of synthesizing peptidoglycan from uridine-5'-diphospho-N-acetyl-muramyl-LAla-i-iso-Glu-L-bys-D-Ala-D-Ala and uridine-5'-diphospho-N-acetyl-D-glucosamine, in contrast with similar preparations from the parental streptococcus. Furthermore, 50-fold higher levels of lipid intermediates which serve as membrane-bound substrates for peptidoglycan synthesis are synthesized in reaction mixtures containing streptococcal membranes than with similar preparations from the L-form. These observations suggest that the inability of this stabilized L-form to form a cell wall in vivo lies, at least in part, in its failure to synthesize significant quantities of the lipid substrates for peptidoglycan synthesis.The pathway by which peptidoglycan is synthesized from uridine-5'-diphospho-N-acetyl-Dmuramyl-L-Ala-D-iso -Glu-L-Lys-D-Ala-D-Ala (UMPPMp) and uridine-5'-diphospho-N-acetyl-D-glucosamine (UDP-GlcNAc) is established. These reactions are catalyzed by membranebound enzymes. In the first step (Fig. 1), phospho-N-acetyl-muramyl-peptapeptide, from UMPPMp, is transferred reversibly from uridine-5'-monophosphate (UMP) to endogenous undecaprenol phosphate (C55OP) by phospho-N-acetyl-i>muramyl-pentapeptide translocase (12). In the second step, incorporation ofN-acetyli-glucosamine from UDP-GlcNAc into undecaprenyl pyrophosphoryl-N-acetyl-D-muramyl-L-300 on August 1, 2020 by guest